Mpox infection is often followed by lingering physical symptoms
A study of adults diagnosed with mpox between May 2022 and January 2023 reveals that over half of the subjects diagnosed with mpox during the 2022 outbreak had… read more.
A study of adults diagnosed with mpox between May 2022 and January 2023 reveals that over half of the subjects diagnosed with mpox during the 2022 outbreak had… read more.
Bavarian Nordic A/S announced the award of a joint procurement contract by the European Commission, through the Health Emergency Preparedness and Response Authority (HERA), enabling the EU, its… read more.
Bavarian Nordic A/S announced that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II variation… read more.
Bavarian Nordic A/S announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of a type II… read more.
Diagnosing infectious conditions can be challenging. Diagnosis is especially challenging for uncommon and emerging infectious diseases for which there’s limited clinical experience. Nevertheless, successfully identifying patients with infectious… read more.
Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers from Karolinska Institutet in Sweden report in a study published… read more.